London Health Sciences Centre (LHSC) has been selected by Intuitive Surgical Inc. — manufacturer of the world's most sophisticated and widely used surgical robot, the da Vinci Surgical System — as the exclusive training centre for robotic surgery in Canada. The training centre will be an integral component of LHSC's innovative Canadian Surgical Technologies and Advanced Robotics (CSTAR) program, known for both its pioneering work in research and development of robotic surgical technologies and its expertise in delivering high quality simulation training for surgeons and other allied healthcare providers.
"Earning the designation as Canada's sole training centre for robotic surgery is a tremendous honour for LHSC and reinforces our position as a world-class centre for surgical innovation and research," said Bonnie Adamson, president and CEO of LHSC in a media release. "The depth of experience and talent that resides within our CSTAR program will now be leveraged to train surgeons from across Canada in the use of the newest generation da Vinci Surgical System. Most importantly, as a result of this training, patients from coast to coast will have more access to minimally invasive procedures, which inevitably will lead to better patient outcomes."
LHSC has recently acquired two state-of-the-art da Vinci Si robotic systems. The national training centre at LHSC will continue to move CSTAR forward in its mission to improve the safety and quality of patient care through surgical innovation.
"With the addition of the two new da Vinci Si systems, we look forward to expanding our nation-leading breadth of robotic surgical practice into new areas for our hospital, such as thoracic, transplant and paediatric surgery," said Dr. Christopher Schlachta, medical director for CSTAR. "It is critical that CSTAR continues to pioneer innovations in medical technology and apply them at the bedside to ensure patients are receiving the highest quality care we can provide."
A vital component of this innovation will be a robust evaluation of the role of robotic technology in surgery, through the ongoing evaluation of clinical effectiveness and cost-efficiency. These findings will be used to help to inform practitioners and policy makers on the efficacy of this technology to ensure that robotic innovation is applied where its results are most effective in improving patient outcomes in Canadian, and indeed global healthcare delivery.